- Home
- AUPH vs DSGR Comparison
AUPH vs DSGR Comparison
Compare AUPH & DSGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- DSGR
- Stock Information
- Founded
- AUPH 1993
- DSGR 1952
- Country
- AUPH Canada
- DSGR United States
- Employees
- AUPH N/A
- DSGR N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- DSGR Industrial Machinery/Components
- Sector
- AUPH Health Care
- DSGR Industrials
- Exchange
- AUPH Nasdaq
- DSGR Nasdaq
- Market Cap
- AUPH 1.4B
- DSGR 1.5B
- IPO Year
- AUPH 1999
- DSGR N/A
- Fundamental
- Price
- AUPH $11.47
- DSGR $28.75
- Analyst Decision
- AUPH Strong Buy
- DSGR Buy
- Analyst Count
- AUPH 2
- DSGR 1
- Target Price
- AUPH $13.00
- DSGR $41.00
- AVG Volume (30 Days)
- AUPH 1.9M
- DSGR 70.1K
- Earning Date
- AUPH 11-06-2025
- DSGR 10-30-2025
- Dividend Yield
- AUPH N/A
- DSGR N/A
- EPS Growth
- AUPH N/A
- DSGR N/A
- EPS
- AUPH 0.42
- DSGR 0.08
- Revenue
- AUPH $260,111,000.00
- DSGR $1,928,948,000.00
- Revenue This Year
- AUPH $17.33
- DSGR $11.30
- Revenue Next Year
- AUPH $14.31
- DSGR $4.13
- P/E Ratio
- AUPH $27.48
- DSGR $352.74
- Revenue Growth
- AUPH 25.59
- DSGR 13.48
- 52 Week Low
- AUPH $6.55
- DSGR $21.87
- 52 Week High
- AUPH $13.54
- DSGR $41.47
- Technical
- Relative Strength Index (RSI)
- AUPH 47.42
- DSGR 39.27
- Support Level
- AUPH $11.08
- DSGR $28.11
- Resistance Level
- AUPH $11.87
- DSGR $30.56
- Average True Range (ATR)
- AUPH 0.62
- DSGR 0.97
- MACD
- AUPH -0.14
- DSGR -0.16
- Stochastic Oscillator
- AUPH 44.06
- DSGR 19.01
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.